Table of Contents:
  • History and development of HMG-CoA reductase inhibitors
  • Structure and mechanisms of action of HMG-CoA reductase inhibitors
  • Sterol-regulatory element binding proteins (SREBPs) : gene-regulatory target of statin action
  • Cellular effects of HMG-CoA reductase inhibitors on blood cells (monocytes, macrophages, platelets)
  • Pleiotropic effects of HMG-CoA reductase inhibitors on cells of the vascular wall
  • Indications and contro-indications for statin treatment (primary and secondary prevention of hypercholestrolemia)
  • Clinical experience : studies with HMG-CoA reductase inhibitors
  • Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease